BBa_K1982010

BBa_K1982010 Version 1

Component

Source:
http://parts.igem.org/Part:BBa_K1982010
Generated By: https://synbiohub.org/public/igem/igem2sbol/1
Created by: Zexu Li
Date created: 2016-10-08 11:00:00
Date modified: 2016-10-18 10:53:31

CRY2-VP64(Eukaryotic LACE system)



Types
DnaRegion

Roles
CDS

Coding

Sequences BBa_K1982010_sequence (Version 1)

Description

{| style="color:black" cellpadding="6" cellspacing="1" border="2" align="right"
! colspan="2" style="background:#FFBF00;"|RBS-CRY2-VP64-HA-FLAG
|-
|Function
|gene activation
|-
|Use in
|Prokaryotic cells
|-
|RFC standard
|RFC 10
|-
|Backbone
|pSB1C3

|-
|Submitted by
|NEU-China 2016
|}

The CRY2/CIBN interaction is entirely genetically encoded. The binding reverses within minutes in the dark, allowing rapid shutoff of transcription by placing samples in the dark. This fusion protein is for use in LACE(light-activated CRISPR/Cas9 effector) system, and a VP64 fused to its C terminus. To regulate DNA transcription by blue light, the system is based on CRY2/CIBN interaction in which a light-mediated protein interaction brings together two protein (tCas9 and an activation domain VP64) . If we remove the stimulation of blue light, dark reversion of CRY2 will dissociate the interaction with CIBN and shut off transcription.

We used the full-length CRY2 (BBa_K1982002) and fused it to the transcription activator domain VP64 (BBa_K1982000). An prokaryotic RBS sequence from the Community collection(BBa_B0034) fused to the beginning of CRY2-VP64. For detection of expression the fusion protein was tagged with a FLAG-epitope coding sequence (gactacaaggacgacgacgacaaa) .Figure 1 illustrates the detailed design of the whole device.



Protein data table for BioBrick BBa_ automatically created by the BioBrick-AutoAnnotator version 1.0
Nucleotide sequence in RFC 10: (underlined part encodes the protein)
 ATGAAGATG ... GACGACAAATAATAA
 ORF from nucleotide position 1 to 2076 (excluding stop-codon)
Amino acid sequence: (RFC 25 scars in shown in bold, other sequence features underlined; both given below)

101 
201 
301 
401 
501 
601 
MKMDKKTIVWFRRDLRIEDNPALAAAAHEGSVFPVFIWCPEEEGQFYPGRASRWWMKQSLAHLSQSLKALGSDLTLIKTHNTISAILDCIRVTGATKVVF
NHLYDPVSLVRDHTVKEKLVERGISVQSYNGDLLYEPWEIYCEKGKPFTSFNSYWKKCLDMSIESVMLPPPWRLMPITAAAEAIWACSIEELGLENEAEK
PSNALLTRAWSPGWSNADKLLNEFIEKQLIDYAKNSKKVVGNCTSLLSPYLHFGEISVRHVFQCARMKQIIWARDKNSEGEESADLFLRGIGLREYSRYI
CFNFPFTHEQSLLSHLRFFPWDADVDKFKAWRQGRTGYPLVDAGMRELWATGWMHNRIRVIVSSFAVKFLLLPWKWGMKYFWDTLLDADLECDILGWQYI
SGSIPDGHELDRLDNPALQGAKYDPEGEYIRQWLPELARLPTEWIHHPWDAPLTVLKASGVELGTNYAKPIVDIDTARELLAKAISRTREAQIMIGAAPD
EIVADSFEALGANTIKEPGLCPSVSSNDQQVPSAVRYNGSKRVKPEEEEERDMKKSRGFDERELFSTAESSSSSSVFFVSQSCSLASEGKNLEGIQDSSD
QITTSLGKNGCKPKKKRKVGRADALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLINYPYDVPDYASDYKDDDDK*
Sequence features: (with their position in the amino acid sequence, see the list of supported features)
SV40 nuclear localization sequence: 613 to 619
HA-tag: 675 to 683
Flag-tag: 685 to 692
Enterokinase cleavage site: 688 to 692
Amino acid composition:
Ala (A)53 (7.7%)
Arg (R)35 (5.1%)
Asn (N)22 (3.2%)
Asp (D)62 (9.0%)
Cys (C)12 (1.7%)
Gln (Q)18 (2.6%)
Glu (E)48 (6.9%)
Gly (G)40 (5.8%)
His (H)13 (1.9%)
Ile (I)37 (5.3%)
Leu (L)71 (10.3%)
Lys (K)44 (6.4%)
Met (M)16 (2.3%)
Phe (F)29 (4.2%)
Pro (P)34 (4.9%)
Ser (S)58 (8.4%)
Thr (T)24 (3.5%)
Trp (W)22 (3.2%)
Tyr (Y)21 (3.0%)
Val (V)33 (4.8%)
Amino acid counting
Total number:692
Positively charged (Arg+Lys):79 (11.4%)
Negatively charged (Asp+Glu):110 (15.9%)
Aromatic (Phe+His+Try+Tyr):85 (12.3%)
Biochemical parameters
Atomic composition:C3518H5403N929O1056S28
Molecular mass [Da]:78505.9
Theoretical pI:4.93
Extinction coefficient at 280 nm [M-1 cm-1]:152290 / 153040 (all Cys red/ox)
Plot for hydrophobicity, charge, predicted secondary structure, solvent accessability, transmembrane helices and disulfid bridges 
Codon usage
Organism:E. coliB. subtilisS. cerevisiaeA. thalianaP. patensMammals
Codon quality (CAI):good (0.69)good (0.73)good (0.68)good (0.76)excellent (0.80)good (0.68)
Alignments (obtained from PredictProtein.org)
   There were no alignments for this protein in the data base. The BLAST search was initialized and should be ready in a few hours.
Predictions (obtained from PredictProtein.org)
   There were no predictions for this protein in the data base. The prediction was initialized and should be ready in a few hours.
The BioBrick-AutoAnnotator was created by TU-Munich 2013 iGEM team. For more information please see the documentation.
If you have any questions, comments or suggestions, please leave us a comment.



Notes

no

Source

CRY2 and CIB1 are extracted from Arabidopsis thaliana. tCas9 is from GE Share company. VP64 is synthetic construct.

Sequence Annotation Location Component / Role(s)
Eukaryotic rbs
ATG
CRY2
SV40 NLS
VP16
VP16
VP16
VP16
Linker
HA
FLAG
TAA
1,18
19,21
22,1854
1855,1875
1876,1914
1915,1953
1954,1992
1993,2031
2032,2037
2037,2063
2071,2094
2095,2100
ribosome_entry_site feature/rbs
feature/start start_codon
feature/protein CDS
feature/misc sequence_feature
sequence_feature feature/misc
sequence_feature feature/misc
sequence_feature feature/misc
feature/misc sequence_feature
sequence_feature feature/misc
feature/tag tag
feature/tag tag
feature/stop stop_codon
igem#status
Planning
 
synbiohub#ownedBy
user/james
 
synbiohub#ownedBy
user/myers
 
synbiohub#topLevel
BBa_K1982010/1
 
","mutableDescription":"{| style=\"color:black\" cellpadding=\"6\" cellspacing=\"1\" border=\"2\" align=\"right\"
\n! colspan=\"2\" style=\"background:#FFBF00;\"|RBS-CRY2-VP64-HA-FLAG
\n|-
\n|Function
\n|gene activation
\n|-
\n|Use in
\n|Prokaryotic cells
\n|-
\n|RFC standard
\n|RFC 10
\n|-
\n|Backbone
\n|pSB1C3

\n|-
\n|Submitted by
\n|NEU-China 2016
\n|}
\n
\nThe CRY2/CIBN interaction is entirely genetically encoded. The binding reverses within minutes in the dark, allowing rapid shutoff of transcription by placing samples in the dark. This fusion protein is for use in LACE(light-activated CRISPR/Cas9 effector) system, and a VP64 fused to its C terminus. To regulate DNA transcription by blue light, the system is based on CRY2/CIBN interaction in which a light-mediated protein interaction brings together two protein (tCas9 and an activation domain VP64) . If we remove the stimulation of blue light, dark reversion of CRY2 will dissociate the interaction with CIBN and shut off transcription.
\n
\nWe used the full-length CRY2 (BBa_K1982002) and fused it to the transcription activator domain VP64 (BBa_K1982000). An prokaryotic RBS sequence from the Community collection(BBa_B0034) fused to the beginning of CRY2-VP64. For detection of expression the fusion protein was tagged with a FLAG-epitope coding sequence (gactacaaggacgacgacgacaaa) .Figure 1 illustrates the detailed design of the whole device.
\n
\n
\n
\n
Protein data table for BioBrick \">BBa_ automatically created by the BioBrick-AutoAnnotator version 1.0
Nucleotide sequence in RFC 10: (underlined part encodes the protein)
 ATGAAGATG ... GACGACAAATAATAA
 ORF from nucleotide position 1 to 2076 (excluding stop-codon)
Amino acid sequence: (RFC 25 scars in shown in bold, other sequence features underlined; both given below)

101 
201 
301 
401 
501 
601 
MKMDKKTIVWFRRDLRIEDNPALAAAAHEGSVFPVFIWCPEEEGQFYPGRASRWWMKQSLAHLSQSLKALGSDLTLIKTHNTISAILDCIRVTGATKVVF
NHLYDPVSLVRDHTVKEKLVERGISVQSYNGDLLYEPWEIYCEKGKPFTSFNSYWKKCLDMSIESVMLPPPWRLMPITAAAEAIWACSIEELGLENEAEK
PSNALLTRAWSPGWSNADKLLNEFIEKQLIDYAKNSKKVVGNCTSLLSPYLHFGEISVRHVFQCARMKQIIWARDKNSEGEESADLFLRGIGLREYSRYI
CFNFPFTHEQSLLSHLRFFPWDADVDKFKAWRQGRTGYPLVDAGMRELWATGWMHNRIRVIVSSFAVKFLLLPWKWGMKYFWDTLLDADLECDILGWQYI
SGSIPDGHELDRLDNPALQGAKYDPEGEYIRQWLPELARLPTEWIHHPWDAPLTVLKASGVELGTNYAKPIVDIDTARELLAKAISRTREAQIMIGAAPD
EIVADSFEALGANTIKEPGLCPSVSSNDQQVPSAVRYNGSKRVKPEEEEERDMKKSRGFDERELFSTAESSSSSSVFFVSQSCSLASEGKNLEGIQDSSD
QITTSLGKNGCKPKKKRKVGRADALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLINYPYDVPDYASDYKDDDDK*
Sequence features: (with their position in the amino acid sequence, see the list of supported features)
SV40 nuclear localization sequence: 613 to 619
HA-tag: 675 to 683
Flag-tag: 685 to 692
Enterokinase cleavage site: 688 to 692
Amino acid composition:
Ala (A)53 (7.7%)
Arg (R)35 (5.1%)
Asn (N)22 (3.2%)
Asp (D)62 (9.0%)
Cys (C)12 (1.7%)
Gln (Q)18 (2.6%)
Glu (E)48 (6.9%)
Gly (G)40 (5.8%)
His (H)13 (1.9%)
Ile (I)37 (5.3%)
Leu (L)71 (10.3%)
Lys (K)44 (6.4%)
Met (M)16 (2.3%)
Phe (F)29 (4.2%)
Pro (P)34 (4.9%)
Ser (S)58 (8.4%)
Thr (T)24 (3.5%)
Trp (W)22 (3.2%)
Tyr (Y)21 (3.0%)
Val (V)33 (4.8%)
Amino acid counting
Total number:692
Positively charged (Arg+Lys):79 (11.4%)
Negatively charged (Asp+Glu):110 (15.9%)
Aromatic (Phe+His+Try+Tyr):85 (12.3%)
Biochemical parameters
Atomic composition:C3518H5403N929O1056S28
Molecular mass [Da]:78505.9
Theoretical pI:4.93
Extinction coefficient at 280 nm [M-1 cm-1]:152290 / 153040 (all Cys red/ox)
Plot for hydrophobicity, charge, predicted secondary structure, solvent accessability, transmembrane helices and disulfid bridges 
Codon usage
Organism:E. coliB. subtilisS. cerevisiaeA. thalianaP. patensMammals
Codon quality (CAI):good (0.69)good (0.73)good (0.68)good (0.76)excellent (0.80)good (0.68)
Alignments (obtained from PredictProtein.org)
   There were no alignments for this protein in the data base. The BLAST search was initialized and should be ready in a few hours.
Predictions (obtained from PredictProtein.org)
   There were no predictions for this protein in the data base. The prediction was initialized and should be ready in a few hours.
The BioBrick-AutoAnnotator was created by TU-Munich 2013 iGEM team. For more information please see the documentation.
If you have any questions, comments or suggestions, please leave us a comment.


\n","mutableNotesSource":"no","mutableNotes":"no
\n","sourceSource":"CRY2 and CIB1 are extracted from Arabidopsis thaliana. tCas9 is from GE Share company. VP64 is synthetic construct.","source":"CRY2 and CIB1 are extracted from Arabidopsis thaliana. tCas9 is from GE Share company. VP64 is synthetic construct.
\n","description":"CRY2-VP64(Eukaryotic LACE system)
\n","comments":[],"labels":[],"canEdit":false,"canUpdate":false,"annotations":[{"type":"uri","name":"igem#status","value":"Planning","nameDef":"http://wiki.synbiohub.org/wiki/Terms/igem#status","id":"igem#status","uri":"http://wiki.synbiohub.org/wiki/Terms/igem#status/Planning","url":"http://wiki.synbiohub.org/wiki/Terms/igem#status/Planning"},{"type":"uri","name":"synbiohub#ownedBy","value":"user/james","nameDef":"http://wiki.synbiohub.org/wiki/Terms/synbiohub#ownedBy","id":"synbiohub#ownedBy","uri":"https://synbiohub.org/user/james","url":"/user/james"},{"type":"uri","name":"synbiohub#ownedBy","value":"user/myers","nameDef":"http://wiki.synbiohub.org/wiki/Terms/synbiohub#ownedBy","id":"synbiohub#ownedBy","uri":"https://synbiohub.org/user/myers","url":"/user/myers"},{"type":"uri","name":"synbiohub#topLevel","value":"BBa_K1982010/1","nameDef":"http://wiki.synbiohub.org/wiki/Terms/synbiohub#topLevel","id":"synbiohub#topLevel","uri":"https://synbiohub.org/public/igem/BBa_K1982010/1","url":"/public/igem/BBa_K1982010/1"}],"triplestore":"public","graphUri":null,"remote":null,"large":false,"encodedProteins":[],"typeFilter":"Show Only Root Objects"}